Tumor bacteria and immune response in prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study looks at bacteria inside prostate tumors and how they affect the immune system. It aims to understand why some prostate cancers grow faster, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older.
- You have been diagnosed with prostate cancer, or you have a benign prostate condition and are having tests or treatment.
- You have had a prostate biopsy, prostate surgery, or other prostate procedure at the First Affiliated Hospital of Anhui Medical University.
- You have leftover tissue samples (like from a biopsy or surgery) that can be used for research.
- Your basic medical information is available, and if needed, you are willing to provide follow-up information.
- If you are asked for new samples or more information, you agree to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at prostate cancer tissue samples to understand how cancer spreads to nearby nerves and what that means for your outlook. By examining the tissue in detail, researchers hope to find better ways to predict and treat prostate cancer.
This trial collects tumor samples from men with prostate cancer to study the bacteria and other microbes inside the tumor. It aims to learn how these microbes might affect the cancer and treatment.
This study collects and measures “biomarkers” (measurable signs in the body) from people with prostate cancer who are about to have surgery or radiation. The goal is to understand how prostate cancer behaves during treatment, which may help improve care in the future.
This trial looks at whether a specific gut bacterium, Akkermansia muciniphila, is linked to how well hormone therapy works in men with advanced prostate cancer that no longer responds to standard hormone treatment. You may join if you are about to start a new type of hormone therapy.
This study looks at how your urine and gut (intestine) microbes change while you undergo prostate cancer treatments, including hormone therapy (androgen deprivation) and/or radiation. The goal is to better understand these biological changes, which may help improve future treatment planning.
This trial studies the “microenvironment” around prostate cancer metastases, using specimens taken during biopsy and other scans. It may help researchers understand what drives prostate cancer spread and improve future treatment choices.
Hear when a new Prostate Cancer (Adenocarcinoma) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.